Novavax Statistics

Share Statistics

Novavax has 162.42M shares outstanding. The number of shares has increased by 1.17% in one year.

Shares Outstanding	162.42M
Shares Change (YoY)	1.17%
Shares Change (QoQ)	0.7%
Owned by Institutions (%)	61.15%
Shares Floating	147.97M
Failed to Deliver (FTD) Shares	182,318
FTD / Avg. Volume	2.29%

Short Selling Information

The latest short interest is 43.08M, so 26.6% of the outstanding shares have been sold short.

Short Interest	43.08M
Short % of Shares Out	26.6%
Short % of Float	26.7%
Short Ratio (days to cover)	9.82

Valuation Ratios

The PE ratio is -6.53 and the forward PE ratio is -418.25. Novavax's PEG ratio is 0.08.

PE Ratio	-6.53
Forward PE	-418.25
PS Ratio	1.79
Forward PS	2.8
PB Ratio	-1.96
P/FCF Ratio	-12.2
PEG Ratio	0.08

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Novavax.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.98, with a Debt / Equity ratio of -0.37.

Current Ratio	0.98
Quick Ratio	0.97
Debt / Equity	-0.37
Debt / EBITDA	-2.13
Debt / FCF	-2.3
Interest Coverage	-12.4

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$716.56K
Profits Per Employee	$-196.95K
Employee Count	952
Asset Turnover	0.44
Inventory Turnover	23.17

Taxes

Income Tax	10.88M
Effective Tax Rate	-6.16%

Stock Price Statistics

The stock price has increased by -32.15% in the last 52 weeks. The beta is 2.5, so Novavax's price volatility has been higher than the market average.

Beta	2.5
52-Week Price Change	-32.15%
50-Day Moving Average	7.01
200-Day Moving Average	7.74
Relative Strength Index (RSI)	65.2
Average Volume (20 Days)	7,955,375

Income Statement

In the last 12 months, Novavax had revenue of 682.16M and earned -187.5M in profits. Earnings per share was -1.23.

Revenue	682.16M
Gross Profit	479.42M
Operating Income	-248.93M
Net Income	-187.5M
EBITDA	-108.04M
EBIT	-156.54M
Earnings Per Share (EPS)	-1.23

Full Income Statement

Balance Sheet

The company has 530.23M in cash and 230.42M in debt, giving a net cash position of 299.81M.

Cash & Cash Equivalents	530.23M
Total Debt	230.42M
Net Cash	299.81M
Retained Earnings	-5.01B
Total Assets	1.34B
Working Capital	530.37M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -87.26M and capital expenditures -13.06M, giving a free cash flow of -100.32M.

Operating Cash Flow	-87.26M
Capital Expenditures	-13.06M
Free Cash Flow	-100.32M
FCF Per Share	-0.66

Full Cash Flow Statement

Margins

Gross margin is 70.28%, with operating and profit margins of -36.49% and -27.49%.

Gross Margin	70.28%
Operating Margin	-36.49%
Pretax Margin	-25.89%
Profit Margin	-27.49%
EBITDA Margin	-15.84%
EBIT Margin	-36.49%
FCF Margin	-14.71%

Dividends & Yields

NVAX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for NVAX is $14, which is 74.1% higher than the current price. The consensus rating is "Hold".

Price Target	$14
Price Target Difference	74.1%
Analyst Consensus	Hold
Analyst Count	6

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 10, 2019. It was a backward split with a ratio of 1:20.

Last Split Date	May 10, 2019
Split Type	backward
Split Ratio	1:20

Scores

Altman Z-Score	-1.56
Piotroski F-Score	5

Novavax Inc. (NVAX)